Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HN25
Term | Name | Level | Count |
---|---|---|---|
GO:0005215 | transporter activity | 1 | 1 |
GO:0005319 | lipid transporter activity | 2 | 1 |
GO:0005548 | phospholipid transporter activity | 3 | 1 |
GO:0008526 | phosphatidylinositol transfer activity | 5 | 1 |
GO:0120013 | lipid transfer activity | 3 | 1 |
GO:0120014 | phospholipid transfer activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.297 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.523 |
CLV_PCSK_KEX2_1 | 355 | 357 | PF00082 | 0.728 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.506 |
CLV_PCSK_PC1ET2_1 | 355 | 357 | PF00082 | 0.656 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.527 |
DEG_APCC_DBOX_1 | 329 | 337 | PF00400 | 0.372 |
DEG_MDM2_SWIB_1 | 251 | 259 | PF02201 | 0.297 |
DOC_CYCLIN_RxL_1 | 108 | 117 | PF00134 | 0.205 |
DOC_MAPK_MEF2A_6 | 220 | 227 | PF00069 | 0.375 |
DOC_PP1_RVXF_1 | 164 | 171 | PF00149 | 0.277 |
DOC_PP1_RVXF_1 | 267 | 273 | PF00149 | 0.279 |
DOC_PP1_RVXF_1 | 309 | 316 | PF00149 | 0.422 |
DOC_PP2B_LxvP_1 | 257 | 260 | PF13499 | 0.400 |
DOC_PP2B_LxvP_1 | 31 | 34 | PF13499 | 0.442 |
DOC_PP4_FxxP_1 | 38 | 41 | PF00568 | 0.358 |
DOC_PP4_FxxP_1 | 47 | 50 | PF00568 | 0.306 |
DOC_USP7_MATH_1 | 277 | 281 | PF00917 | 0.509 |
DOC_USP7_UBL2_3 | 334 | 338 | PF12436 | 0.627 |
DOC_USP7_UBL2_3 | 340 | 344 | PF12436 | 0.657 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.614 |
LIG_14-3-3_CanoR_1 | 249 | 254 | PF00244 | 0.229 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.557 |
LIG_deltaCOP1_diTrp_1 | 202 | 210 | PF00928 | 0.277 |
LIG_EVH1_2 | 247 | 251 | PF00568 | 0.322 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.469 |
LIG_FHA_2 | 206 | 212 | PF00498 | 0.295 |
LIG_FHA_2 | 266 | 272 | PF00498 | 0.361 |
LIG_LIR_Apic_2 | 304 | 309 | PF02991 | 0.514 |
LIG_LIR_Apic_2 | 36 | 41 | PF02991 | 0.356 |
LIG_LIR_Apic_2 | 45 | 50 | PF02991 | 0.330 |
LIG_LIR_Gen_1 | 105 | 115 | PF02991 | 0.312 |
LIG_LIR_Gen_1 | 121 | 131 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 202 | 210 | PF02991 | 0.246 |
LIG_LIR_Gen_1 | 211 | 217 | PF02991 | 0.252 |
LIG_LIR_Gen_1 | 87 | 97 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 105 | 110 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 121 | 127 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 202 | 207 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 208 | 213 | PF02991 | 0.166 |
LIG_LIR_Nem_3 | 252 | 258 | PF02991 | 0.286 |
LIG_LIR_Nem_3 | 283 | 288 | PF02991 | 0.357 |
LIG_MYND_1 | 286 | 290 | PF01753 | 0.479 |
LIG_NRBOX | 109 | 115 | PF00104 | 0.193 |
LIG_PCNA_yPIPBox_3 | 83 | 91 | PF02747 | 0.251 |
LIG_Pex14_2 | 251 | 255 | PF04695 | 0.262 |
LIG_Pex14_2 | 285 | 289 | PF04695 | 0.338 |
LIG_SH2_CRK | 306 | 310 | PF00017 | 0.537 |
LIG_SH2_NCK_1 | 306 | 310 | PF00017 | 0.532 |
LIG_SH2_STAP1 | 213 | 217 | PF00017 | 0.172 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 296 | 299 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.411 |
LIG_SH3_1 | 306 | 312 | PF00018 | 0.543 |
LIG_SH3_3 | 306 | 312 | PF00018 | 0.425 |
LIG_TRAF2_1 | 325 | 328 | PF00917 | 0.483 |
LIG_TRAF2_1 | 54 | 57 | PF00917 | 0.384 |
LIG_UBA3_1 | 250 | 256 | PF00899 | 0.395 |
LIG_WW_3 | 246 | 250 | PF00397 | 0.172 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.615 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.712 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.551 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.483 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.384 |
MOD_CK2_1 | 15 | 21 | PF00069 | 0.546 |
MOD_CK2_1 | 205 | 211 | PF00069 | 0.295 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.428 |
MOD_CK2_1 | 265 | 271 | PF00069 | 0.400 |
MOD_CK2_1 | 277 | 283 | PF00069 | 0.496 |
MOD_CK2_1 | 322 | 328 | PF00069 | 0.478 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.373 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.637 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.345 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.445 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.610 |
MOD_GSK3_1 | 205 | 212 | PF00069 | 0.270 |
MOD_GSK3_1 | 277 | 284 | PF00069 | 0.521 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.246 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.319 |
MOD_N-GLC_1 | 301 | 306 | PF02516 | 0.394 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.324 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.410 |
MOD_NEK2_1 | 297 | 302 | PF00069 | 0.264 |
MOD_PK_1 | 249 | 255 | PF00069 | 0.287 |
MOD_Plk_4 | 284 | 290 | PF00069 | 0.464 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.289 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.613 |
MOD_SUMO_for_1 | 336 | 339 | PF00179 | 0.419 |
MOD_SUMO_rev_2 | 172 | 182 | PF00179 | 0.400 |
MOD_SUMO_rev_2 | 214 | 222 | PF00179 | 0.400 |
TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.297 |
TRG_Pf-PMV_PEXEL_1 | 229 | 233 | PF00026 | 0.400 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHG0 | Leptomonas seymouri | 74% | 96% |
A0A0S4IKI1 | Bodo saltans | 46% | 100% |
A0A1X0P588 | Trypanosomatidae | 51% | 100% |
A0A3Q8IJP6 | Leishmania donovani | 77% | 99% |
A0A3R7L5B2 | Trypanosoma rangeli | 56% | 100% |
A4IBP3 | Leishmania infantum | 77% | 99% |
C9ZYY3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AFI0 | Leishmania major | 80% | 100% |
E9B6N5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 99% |
Q55CU8 | Dictyostelium discoideum | 26% | 100% |
V5BCV8 | Trypanosoma cruzi | 55% | 100% |